Zein-alpha 19A2 Antibody

What is Zein-alpha 19A2 and why is it important in plant research?

Zein-alpha 19A2 is a specific 19 kDa alpha-zein variant belonging to the zein family of storage proteins found in maize (Zea mays) seeds. Zeins are classified into α-, β-, γ- and δ-types, with the alpha-zeins being the most abundant storage proteins in maize endosperm . The 19A2 designation refers to a specific variant with UniProt accession number P06674.

These proteins are significant in research for several reasons:

• They serve as principal nitrogen repositories in maize kernels

• They influence the nutritional quality of maize (particularly affecting lysine content)

• They affect kernel texture and hardness characteristics

• They are regulated by transcription factors including Opaque2 (O2) and ZmMADS47

• They can be targets for genetic modification to improve nutritional properties

Studying Zein-alpha 19A2 contributes to our understanding of seed development, protein storage mechanisms, and provides opportunities for crop quality improvement through genetic engineering.

What experimental techniques commonly employ Zein-alpha 19A2 antibodies?

Zein-alpha 19A2 antibodies are utilized in multiple experimental techniques:

When using these antibodies, researchers should be aware that experimental conditions may affect epitope accessibility and antibody binding efficiency.

How are Zein-alpha 19A2 antibodies validated for research applications?

Validation of Zein-alpha 19A2 antibodies typically involves multiple complementary approaches:

• Western blot analysis: Confirming binding to proteins of the expected molecular weight (approximately 19 kDa)

• Knockout verification: Testing antibody reactivity in RNAi lines or CRISPR-edited material where zein expression is reduced

• Cross-reactivity assessment: Testing against related zein proteins to determine specificity

• Epitope mapping: Identifying the specific sequence recognized by the antibody

• Purified protein controls: Using recombinant or purified zein proteins as positive controls

For example, researchers have used western blot analysis with ZmMADS47-specific antibody to confirm "a marked reduction of ZmMADS47 protein in RNAi lines," demonstrating how genetic knockdown approaches can validate antibody specificity .

What are the key characteristics of commercially available Zein-alpha 19A2 antibodies?

Based on available commercial information, Zein-alpha 19A2 antibodies typically have the following characteristics:

Most commercially available antibodies are supplied in a liquid form with recommended storage at -20°C and are validated primarily for ELISA and Western blot applications .

How does the regulatory network affecting zein gene expression impact antibody selection and experimental design?

The complex transcriptional regulation of zein genes significantly impacts antibody-based detection strategies:

• Transcription factor interactions: ZmMADS47 and Opaque2 (O2) form a protein complex that co-regulates multiple zein genes. ZmMADS47 specifically binds a CATGT motif in the promoters of α-zein and 50-kD γ-zein genes . When designing experiments, researchers must consider how mutations in one transcription factor might affect the expression of multiple zein subtypes.

• Temporal regulation: Zein expression varies during kernel development, with peak accumulation typically occurring 15-25 days after pollination (DAP) . Antibody-based experiments should be timed accordingly.

• Promoter binding preferences: ZmMADS47 and O2 have different binding preferences for zein gene promoters, with ZmMADS47 preferentially binding the Z2 motif in the z1A promoter and the 50-1 motif in the 50-kD γ-zein promoter, while O2 prefers the Z1 motif and the 50-2 motif . This differential binding affects which zein genes are expressed under different conditions.

For robust experimental design:

• Include multiple developmental time points

• Consider genetic background effects

• Use antibodies targeting multiple zein subtypes to assess compensatory effects

• Include appropriate controls accounting for known regulatory factors

What methodological considerations are crucial when using Zein-alpha 19A2 antibodies in protein interaction studies?

When investigating protein interactions involving Zein-alpha 19A2, researchers should consider:

Interaction preservation techniques:

• Buffer conditions must maintain native interactions while enabling antibody binding

• Mild detergents may be necessary to solubilize membrane-associated protein bodies

• Cross-linking agents can stabilize transient interactions

• Temperature control during sample preparation is critical

Validation approaches:

• Reciprocal co-immunoprecipitation (Co-IP) with antibodies against suspected interaction partners

• Gel filtration to isolate protein complexes by size followed by immunoblotting

• GST pull-down assays with recombinant proteins to confirm direct interactions

• Controls using non-specific antibodies of the same isotype

From research on zein-regulating transcription factors: "Extract from immature kernels (15 DAP) was filtered by molecular weight using a Superdex 200 10/300GL Column (GE Healthcare) to separate protein complexes. The eluted fractions were analyzed by SDS-PAGE and immunoblotted with O2-specific or ZmMADS47-specific antibodies" . Both O2 and ZmMADS47 were detected in the same fractions, confirming their presence in a ~550 kDa complex.

How can Zein-alpha 19A2 antibodies be employed in genetic engineering of maize for improved nutritional quality?

Zein-alpha 19A2 antibodies serve as critical tools in monitoring and characterizing genetically modified maize lines:

Applications in genetic engineering research:

• Quantifying zein reduction in lines edited to improve lysine content

• Monitoring compensatory changes in other zein proteins following genetic modification

• Characterizing protein body morphology changes in modified lines

• Assessing the stability of modifications across generations

Recent research demonstrated that "editing the 19 kDa alpha-zein family alone can enhance lysine while retaining vitreous endosperm and a functional O2 transcription factor" . Using CRISPR/Cas9 to target the 19 kDa subclass resulted in up to 30% more lysine content while maintaining kernel hardness. Researchers identified edited lines using SDS-PAGE analysis of zein content, where antibodies could provide more sensitive detection.

Methodological workflow:

• Design genetic modifications targeting specific zein genes

• Generate edited plants using CRISPR/Cas9 or RNAi

• Screen transformants using PCR and preliminary protein analysis

• Confirm protein changes using Western blot with zein antibodies

• Quantify relative abundance changes across zein subtypes

• Correlate protein changes with nutritional quality improvements

What strategies can overcome the challenges in distinguishing between closely related zein variants using antibodies?

The alpha-zein gene family consists of multiple members with high sequence similarity, creating challenges for specific detection:

Challenges and solutions:

Advanced specificity approaches:

• Epitope mapping: Identify the exact binding region of each antibody

• Competitive ELISA: Use variant-specific peptides to determine relative affinities

• Combined genetic and immunological approaches: Compare antibody reactivity patterns in lines with specific zein gene knockouts

• Mass spectrometry validation: Confirm the identity of immunoprecipitated proteins

Research on zein regulation notes that expression of different zein genes responds differently to mutations in regulatory factors, with "expression of z1C (22-kD) α zeins and the 14-kD β-zein severely reduced, while the 19-kD zeins only partially reduced, and other zeins barely affected" , highlighting the complexity of the zein family.

How do post-translational modifications affect detection of Zein-alpha 19A2 using antibodies?

Post-translational modifications (PTMs) can significantly impact antibody binding to Zein-alpha 19A2 proteins:

Potential PTMs in zein proteins:

• Phosphorylation of serine/threonine residues

• Disulfide bond formation

• Glycosylation

• Proteolytic processing of signal peptides

• Terminal modifications

Factors affecting antibody-based detection:

• PTMs may directly block epitope recognition

• Modifications can alter protein conformation, affecting antibody binding

• Processing of signal peptides may remove N-terminal epitopes

• Developmental changes in PTM patterns may affect detection at different growth stages

Strategies for addressing PTM-related challenges:

• Use multiple antibodies targeting different epitopes

• Employ modification-specific antibodies when available

• Include enzymatic treatments to remove specific modifications before analysis

• Compare native and denatured detection methods

• Consider how extraction methods might affect PTM preservation

While not specific to zein proteins, research on antibody development demonstrates the importance of considering PTMs: "To increase the likelihood of generating antibodies with epitopes in the N-terminal and/or the NAC region of the protein, we used [protein] 1-20 peptide as well as human full-length (1-140) and [protein] 1-119 recombinant proteins as immunogens" .

What are the implications of conformational diversity in Zein-alpha proteins for antibody development and experimental interpretation?

Zein proteins can adopt various conformations, which has significant implications for antibody-based research:

Conformational considerations:

• Zein proteins contain both α-helical and β-sheet regions that contribute to their packing in protein bodies

• Environmental conditions (pH, ionic strength, temperature) can affect protein conformation

• Interactions with other proteins may induce conformational changes

• Extraction methods can affect native structure preservation

Research has investigated "Conformations of a highly expressed Z19 α-zein" using computational modeling: "The protein sequence for the α-zein cZ19C2 excluding signal peptide (residues 1-21) was obtained via the accession number P06677 from UniProtKB. The sequence was submitted via the ColabFold web-interface to generate AlphaFold2 models" .

Impact on antibody applications:

• Some antibodies may recognize conformational epitopes that are only present in certain structural states

• Denaturation during Western blotting may expose epitopes that are hidden in the native state

• Fixation methods for immunohistochemistry may preserve or disrupt specific conformations

• Antibody affinity may vary with conformational state

Notably, research on antibody binding characteristics has shown that "A single antibody was shown to adopt different binding-site conformations and thereby bind unrelated antigens" . This multispecificity phenomenon suggests antibodies themselves exhibit conformational diversity that affects their binding properties.

Best practices:

• Validate antibodies under conditions matching the intended application

• Use complementary techniques to assess protein conformation alongside antibody binding

• Consider native versus denaturing conditions when interpreting results

• Employ multiple antibodies targeting different regions of the protein